Navigating supply chains and product portfolios during a pandemic

Artificial Intelligence (AI) is rapidly becoming an important tool across the pharmaceutical and biotechnology sectors, with applications ranging from process monitoring and predictive analytics to deviation detection and classification. As AI adoption accelerates by...

The success of a cell therapy extends well beyond development and GMP manufacturing. It also depends on the ability to deliver the product safely, reliably, and under tightly controlled conditions. Unlike traditional pharmaceuticals, cell therapies are highly...

By 2025, the global advanced therapy medicinal products (ATMP) sector, encompassing cell therapies, gene therapies, and genetically modified cell-based medicines, has progressed from early scientific success to clinical and commercial reality. Following a decade of...